Results 301 to 310 of about 1,459,292 (318)

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

Nature Medicine, 2002
C. Sgadari, G. Barillari, E. Toschi, D. Carlei, I. Bacigalupo, S. Baccarini, C. Palladino, P. Leone, R. Bugarini, L. Malavasi, A. Cafaro, M. Falchi, D. Valdembri, G. Rezza, F. Bussolino, P. Monini, B. Ensoli   +16 more
semanticscholar   +1 more source

Substitution for Protease Inhibitors in HIV Therapy

New England Journal of Medicine, 2003
openaire   +3 more sources

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.

Cancer Research, 2005
Anjali K. Gupta, G. Cerniglia, R. Mick, W. Mckenna, R. J. Muschel   +4 more
semanticscholar   +1 more source

Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality

Bioorganic and Medicinal Chemistry Letters, 2007
Ding Lu, Robert Vince
exaly  

HIV protease inhibitors

2012
BOYD MICHAEL JOHN, MOLINARO CARMELA, ROY AMELIE, TRUONG VOUY LINH   +3 more
openaire   +2 more sources

New, potent P1/P2-morpholinone-based HIV-protease inhibitors

Bioorganic and Medicinal Chemistry Letters, 2006
Wieslaw M Kazmierski
exaly  

HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.

Antiviral Research, 2000
J. Lenhard, E. Furfine, R. Jain, O. Ittoop, L. Orband-Miller, S. Blanchard, M. Paulik, J. Weiel   +7 more
semanticscholar   +1 more source

Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group

ACS Medicinal Chemistry Letters, 2016
Joseph P Vacca, Carmela Molinaro, Philippe G Nantermet   +2 more
exaly  

Inhibitors of HIV Protease

2016
A. Wlodawer, M. Jaskolski
openaire   +1 more source

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection

Expert Opinion on Investigational Drugs, 2003
Saurabh Mehandru, Martin Markowitz
exaly